Clinical Infectious Diseases: Bone and Joint, Skin and Soft Tissue

1124

Sequential Intravenous High Dose Oral Antibiotics in the Treatment of Osteoarticular Infections in Children - A Randomised Controlled Trial
Karen Tsui, MBChB, FRACP ; Haemish Crawford, MBChB, FRACS ; Florina Chan Mow, MBChB ; Rachel Webb, MBChB ; Lesley M. Voss, MB, ChB ; N. Susan Stott, MBChB, FRACS ; Joanna Stewart, MSc ; Diana R. Lennon, MB, ChB

Posters

OM poster IDSA Tsui 10202016.pdf (534.4 kB)

1125

In-Depth Analysis of Oral vs Parenteral Therapy in Pediatric Acute Hematogenous Osteomyelitis
Zaid Alhinai, MD ; Brian Lee, MPH, PhD ; Penelope H. Dennehy, MD, FIDSA, FPIDS ; Michael Koster, MD ; Ian C. Michelow, MD, DTM&H

Posters

IDweek 2016 Poster - Osteomyelitis 3x6.pdf (133.7 kB)

1126

Clinical Use of Ceftaroline Fosamil for the Treatment of Gram-Positive Osteomyelitis
Leonard B. Johnson, MD, FIDSA ; Jose Vazquez, MD, FACP, FIDSA ; Ananthakrishnan Ramani, MD ; David Guervil, PharmD

Posters

Osteomyelitis IDW 2016(CEF16079.3003).pdf (1.2 MB)

1127

Bone and Joint Infections among Hematopoietic Stem cell transplant (HSCT) Recipients
Cybele Lara Abad, MD ; Vania Phuoc, MD ; Prashant Kapoor, MD ; Aaron Tande, MD ; Irene Sia, MD ; Pritish K. Tosh, MD ; D Osmon, MD

Posters

Bone and Joint Final ppt .pdf (888.8 kB)

1128

Factors for neurologic sequelae in patients with hematogenous vertebral osteomyelitis
Yu-Mi Lee, MD ; Hyun Jung Park, MD ; Ki-Ho Park, MD ; Oh-Hyun Cho, MD ; Seong Yeon Park, MD ; Chisook Moon, MD ; Sung-Han Kim, MD ; Sang-Oh Lee, MD ; Sang-Ho Choi, MD ; In-Gyu Bae, MD ; Yang Soo Kim, MD ; Jun Hee Woo, MD ; Mi Suk Lee, MD, PhD

1129

Describing Infections of the Spine treated with Ceftaroline: The DISC Study-preliminary results
Richard R. Watkins, MD, MS, FACP ; Steven a. Burdette, MD, FIDSA ; Nairmeen Haller, MS/PhD ; Robert A. Bonomo, MD

Posters

1129_IDWPOSTER_45X60_PRINT.png (3.0 MB)

1130

Descriptive Epidemiology of the Radiographic Findings in Pediatric Osteomyelitis with a Focus on Plain Films: A Five Year Experience at a Tertiary Children’s Hospital
Natalia Liu, Medical Student ; Thomas Fox, MD

Posters

IDSA Poster Presentation_FINAL_pdf.pdf (331.0 kB)

1131

Real-World Use ofTelavancin in the Treatment of Osteomyelitis
Louis Saravolatz, MD, FIDSA ; Cedric W. Spak, MD ; Ali Hassoun, MD FIDSA FACP ; Kerry Cleveland, MD ; Khaled Rikabi, MD, MBA ; Joseph Reilly, PharmD, CGP ; Susan Szpunar, PhD ; Sharon Valenti, MSN, ACNP ; Leonard B. Johnson, MD, FIDSA

1132

Bone and Joint Infections in Acute Myelogenous Leukemia: A Retrospective Review of Patients at Mayo Clinic
Vania Phuoc, MD ; Cybele Lara Abad, MD ; Aaron Tande, MD ; Irene Sia, MD ; Pritish K. Tosh, MD ; Prashant Kapoor, MD ; Douglas Osmon, MD

Posters

Bone and Joint Infections in AML.png (420.6 kB)

1133

Clinical Experience Treating Vertebral Osteomyelitis at University of Louisville Hospital
Julie Harting, PharmD ; Kim Buckner, Program Coordinator ; Francisco Fernandez, MD ; Robert Kelley, PhD ; Paula Peyrani, MD ; Julio Ramirez, MD

Posters

Vertebral Osteomyelitis IDWeek 2016 Poster PDF.pdf (375.4 kB)

1134

A Rare Case of Septic Arthritis Caused by β-lactamase Producing Neisseria elongata
Seyed Hosseini, B.S. ; Arthur Winer, MD ; Hannah Park, MD ; Jonathan Chun, MD ; Su Jung Yoo, BS ; Matthew Shou Lun Lee, MD

Posters

AliKhalessi_Poster.pdf (392.5 kB)

1135

Septic Arthritis in ESRD
Matthew Winn, BS ; Jennifer Waller, PhD ; N Stanley Nahman Jr., MD ; Lu Huber, MD ; Stephanie Baer, MD ; Mufaddal Kheda, MD ; Rhonda Colombo, MD

Posters

SA Poster for IDSA.pdf (1.7 MB)

1136

Epidemiology and Clinical Features of Kingella Septic Arthritis among Children in NYC
Joselito Sanchez, MD ; Henry Pollack, MD

Posters

Kingella Poster IDSA.pdf (702.8 kB)

1137

Culture-Negative Septic Arthritis in Children
Evangelos Spyridakis, MD ; Laura Anatale-Tardiff, MPH ; Jeffrey S. Gerber, MD, PhD ; Ari B. Frosch, MD Candidate ; Joseph W. St. Geme III, MD, FPIDS ; Eric Porsch, PhD ; Kevin Downes, MD

1138

Identification of Prosthetic Joint Pathogens Directly in Clinical Specimens by Metagenomic Shotgun Sequencing
Matthew Thoendel, MD, PhD ; Patricio Jeraldo, PhD ; Kerryl Greenwood-Quaintance, MS ; Janet Yao, PhD ; Matthew Abdel, MD ; Nicholas Chia, PhD ; Robin Patel, MD, FIDSA, D(ABMM) ; Arlen D. Hanssen, MD

1139

Prosthetic Joint Infection: A Single Center Study Comparing DAIR (Debridement, Antibiotics, Irrigation, and Retention) vs. Exchange Arthroplasty
Francisco Salgueiro, MD ; Mary Lasalvia, MD, MPH ; Christopher Rowley, MD/MPH ; Adolf Karchmer, MD, FIDSA

Posters

Salgueiro - ID Week PJI.pdf (422.4 kB)

1140

Two-year Outcomes of Infected Total Hip Arthroplasty (THA) Treated With Debridement and Implant Retention
Andy Miller, MD ; Michael Henry, MD ; Devin Williams, MPH ; Scott Nodzo, MD ; Eileen Finerty, FNP CIC ; Allina Nocon, MPH ; Barry Brause, MD ; Geoffrey Westrich, MD

1141

Treatment of prosthetic joint infection: DAIR with short duration of rifampicin.
Henk Scheper, MD ; Daphne Van Hooven, Medical student ; Michiel Van De Sande, MD, PhD ; Stefan De Boer, MD ; Rachid Mahdad, MD ; Martha Van Der Beek, MD, PhD ; Leo Visser, MD PhD ; Mark De Boer, MD PhD ; Rob Nelissen, MD PhD

Posters

Poster IDSA 2016.pdf (382.7 kB)

1142

Utilization of Ultrasonic Frequencies (Sonication) and Target Enriched Multiplex Polymerase Chain Reaction (TEM-PCR) in Identifying Elusive Prosthetic Joint Infections (PJI)
Ali Hassoun, MD FIDSA FACP ; Patti Hopkins, RN BSN MSHA ; Michael Miller, PhD

Posters

Sonication Poster_proof2.pdf (177.5 kB)

1143

Decreasing incidence of skin and soft tissue infections with a persistent summer peak at an academic medical center, 2006-2014
Ethan Morgan, BS ; Robert S Daum, MD, FIDSA ; Michael Z David, MD PhD

1144

Decision-Making for Management of Skin and Soft Tissue Infections
Deepthi Sudhakar, M.D. ; Rahul S. Kamath, B.S. ; Julianna Gardner, B.A. ; Hassan Kamran, M.D. ; Daniel M. Musher, MD

1145

Hospital Cost and Reimbursement for Acute Bacterial Skin and Skin Structure Infections: A Retrospective Observational Analysis of Admissions Using 2014 Medicare Claims Data
Katelyn R. Keyloun, PharmD, MS ; Qi Zhao, MD, MPH ; Joanna Young, MPP ; Patrick Gillard, PharmD, MS

Posters

MedPAR(DAL16075.3003).pdf (1.1 MB)

1146

Economic Burden of Inpatient Stays for Patients with Acute Bacterial Skin and Skin Structure Infections in the United States: A Retrospective Observational Analysis of Premier Hospital Admissions
Katelyn R. Keyloun, PharmD, MS ; David J. Weber, MD, MPH, FIDSA, FSHEA ; Qi Zhao, MD, MPH ; Michael Ganz, PhD, MS ; Betsey Gardstein, MSPH ; Patrick Gillard, PharmD, MS

Posters

Premier IDW(DAL16075.3002).pdf (1.3 MB)

1147

Identification of Patient Characteristics Associated with Rapid Clinical Response in Hospitalized Patients with Skin and Soft Tissue Infections (SSTIs)
Amy Chang, MD, PharmD ; Jared Borlagdan, Pharmacy student ; Carol Chenoweth, MD, MS, FSHEA, FIDSA ; Tejal Gandhi, MD ; Jerod Nagel, PharmD

1148

Using the Q Score and Q234 Score to Decrease Unnecessary Pathogen Reporting in Wound Cultures
April Dyer, PharmD, MBA, MSCR, BCPS ; Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS ; Obiefuna Okoye, MD, MPH

Posters

Wound Poster final edit.pdf (306.6 kB)

1149

Predictors of Mortality following Incident Diabetic Foot Ulcers
Meghan Brennan, MD ; Timothy Hess, PhD ; Brian Bartle, MPH ; Jennifer Cooper, MPH ; Jonathan Kang, DPM ; Maureen Smith, MD, PhD ; Min-Woong Sohn, PhD ; Christopher Crnich, MD, PhD

Posters

IDSA poster resized 1024 x 768.pdf (562.0 kB)

1150

Recurrent Skin and Soft Tissue Infections in Emergency Department Patients in California, 2005-2011
Larissa May, MD, MSPH ; Eili Klein, PhD ; Loren Miller, MD, MPH ; Elena Martinez, MS, MPH ; Nestor Mojica, MS

1151

Knowledge, attitudes, and practices associated with the diagnosis and management of skin and soft tissue infections among medical students, residents, and attending physicians.
Norman Beatty, MD ; Jessica August, MD ; Joe Anthony Saenz, MD ; David Nix, PharmD ; Kathryn Matthias, PharmD ; Mayar Al Mohajer, MD FACP

Posters

Beatty IDSA SSTI survey poster.pdf (617.0 kB)

1152

Obesity Contributes to Failure of Outpatient Treatment of Skin and Soft Tissue Infections
Erin Conway, PharmD ; John Sellick, D.O., M.S., FIDSA, FSHEA ; Kari Kurtzhalts, PharmD ; Kari Mergenhagen, Pharm.D., BCPS AQ-ID

Posters

Conway Opt Skin and Soft Tissue Infection ID WEEK POSTER FINAL 10.6.pdf (340.3 kB)

1153

Comparison of Delafloxacin (DLX) and Vancomycin (VAN) by Age and Gender in Two Phase 3 Trials in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)
Eric Hansen, MD ; Sergiu Ungureanu, MD ; Borislav Ninov Sr., MD, PhD ; Oscar Pamo Reyna, MD ; Megan Quintas, BS ; Laura Lawrence, B.S. ; Sue K. Cammarata, M.D.

Posters

IDWeek 2016 age gender FINAL.10.6.pdf (346.7 kB)

1154

Evaluation of Digital vs. Manual Measures of Lesion Size in a Phase 3 Trial of Delafloxacin (DLX) in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Michael Jaharis, B.S.c. ; Dipali Patel, M.P.H. ; Laura Lawrence, B.S. ; Megan Quintas, BS ; Carol Tseng, Ph.D. ; Sue K. Cammarata, M.D.

Posters

Slide1.png (600.7 kB)

1155

Epidemiology and risk factors for hospitalization in patients with lower extremity cellulitis: A population-based study
Jasmine R. Marcelin, MD ; Eugene M. Tan, MD ; Douglas Challener, MD ; Brian Lahr, MS ; Larry M. Baddour, MD, FIDSA

Posters

epidemiology poster_v4.pdf (1.2 MB)

1156

Shewanella algae Infection in United States Naval Special Warfare Trainees
Kristi Stone-Garza, MD, MPH ; Paul Graf, PhD, D(ABMM) ; Daniel Croom, MD ; Mari Brown, MPH, MS ; Cheryl Andreoli, PhD ; Peter Woodson, MD ; Ryan Maves, MD, FIDSA

Posters

IDWeek Shewanella Poster - KSG.pdf (1003.4 kB)

1157

Treatment of Cellulitis in Patients Discharged from the Emergency Room: Appropriateness of Single versus Dual Antimicrobial Therapy.
Henry Lederer, PharmD ; Yelena Atlasevich, PharmD ; Eva Sullivan, PharmD ; Harminder Sikand, PharmD, FCSHP, FASHP

1158

Microbiological profile of combat-related extremity wound infections: Trauma Infectious Disease Outcomes Study 2009-2012
Laveta Stewart, PhD, MSc, MPH ; Faraz Shaikh, MS ; William P. Bradley, MS ; Dan Z. Lu, MS ; Dana M. Blyth, M.D. ; Elizabeth Schnaubelt, MD ; Timothy Whitman, DO ; Margot Krauss, MD, MPH, FACPM ; Lauren Greenberg, MPH ; Katrin Mende, PhD ; David Tribble, MD, DrPH, FIDSA

1159

The Natural History of Antibiotic-Treated Limb Cellulitis: Data Derived from a Randomised Trial of Cellulitis of over 400 Patients Allows the Determination of Time to Recovery and Clarifies the Utility of Systemic Observations, Blood Tests, Pain Scores and Local Limb Measurements.
Richard Brindle, MD

Posters

Poster ISDA2016BrindleNaturalHistory1slide.pdf (839.6 kB)

1160

Atypical Fournier’s Gangrene: Gastrointestinal Perforation Associated with Necrotizing Fasciitis Involving the Abdominal Wall, Flank, or Lower Extremities.
Nicolas Cortes-Penfield, MD ; Hanine El-Haddad, MD ; Daniel M. Musher, MD

Posters

IDWeek 2016 - Atypical Fourniers Poster Final.pdf (774.2 kB)

1161

The dilemma of poor diagnosis of concurrent chronic venous disease (CVD) in the setting of lower limb (LL) cellulitis
Adrienne Torda, PhD ; Manoshi Perera, Medical Student

Posters

ID week 2016 cellulitis and CVD poster corrected.pdf (289.7 kB)

1162

Clinical Usefulness of Real-Time Polymerase Chain Reaction for the Diagnosis of Vibrio vulnificus Infection Using Skin and Soft Tissues
Dong-Min Kim, M.D., PhD. ; Na Ra Yun, M.D., PhD. ; Choon-Mee Kim, Ph.D

1163

Necrotizing Fasciitis (NF) Within the First 72 Hours After Presentation With Skin and Skin Structure Infection
Urania Rappo, MD ; Sailaja Puttagunta, MD ; Michael Dunne, MD

Posters

Necrotizing Fascitis IDW.pdf (1.2 MB)

1164

In vitro Activity of Ceftaroline Against Skin and Soft Tissue and Respiratory Pathogens Isolated from Latin America
Douglas Biedenbach, MS ; Meredith Hackel, PhD, MPH ; Joseph Iaconis, PhD ; Dan Sahm, PhD

Posters

AZ_P2_CPT_LATAM_IDSA2016_v01 final.pdf (713.0 kB)

1165

Breast infections following mastectomy and reconstruction in breast oncology patients.
Elizabeth Robilotti, MD MPH ; Christopher Calero, BS ; Jennifer Brite, MPH ; Joseph Disa, MD ; Mini Kamboj, MD

1166

Comparative-Effectiveness of Ceftaroline and Daptomycin as First-line Therapy for Patients with Skin and Soft Tissue Infections Admitted to Hospitals in the United States Veterans Health Care System
Rachel S. Britt, PharmD Student ; Grace C. Lee, PharmD, PhD ; Kelly R. Reveles, PharmD, PhD ; Natalie K. Boyd, PharmD, MS ; Kirk E. Evoy, PharmD ; Christopher R. Frei, PharmD, MSc

1167

Risk Factors Associated with Methicillin-Resistant Staphylococcus aureus (MRSA) Complicated Skin and Soft Tissue Infection (CSSTIs) in Colombia
Sandra Liliana Valderrama Beltran, MD ; Sandra Gualtero, MD ; Jose Rodriguez, MD ; Johanna Osorio, MD ; Carlos Arturo Alvarez Moreno, Physician infectious diseases ; Fabian Gil, MD ; Carlos Gomez Quintero, MD ; Maria Alejandra Caro, MD ; Sebastian Mackenzie, MD ; Gerson Arias, MD ; Cesar Arias, MD, PhD, FIDSA

Posters

poster SSTI S. aureus Colombia.pdf (171.6 kB)

Navigation

Browse by Day:

Browse by Track: